Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors

作者: Sonali Rudra , Nidhi Gupta , Lalit Kumar Baregama , Ritu Agarwal , Vinayak Vasantrao Khairnar

DOI:

关键词:

摘要: The present invention relates to phosphodiesterase (PDE) type 4, 7 and dual PDE 4 /PDE inhibitors. Compounds disclosed herein having the structure of Formura 1: can be useful in treatment, prevention, inhibition or suppression CNS diseases, for example, multiple sclerosis; various pathological conditions such as diseases affecting immune system, including AIDS, rejection transplant, auto-immune disorders T-cell related rheumatoid arthritis; inflammatory respiratory inflammation chronic obstructive pulmonary disease (COPD), asthma, bronchitis, allergic rhinitis, adult distress syndrome (ARDS) other but not limited psoriasis, shock, atopic dermatitis, eosinophilic granuloma, conjunctivitis, osteoarthritis; gastrointestinal Crohn's disease, colitis, pancreatitis well different types cancers leukaemia; especially humans. Processes preparation compounds, pharmaceutical compositions containing compounds their use inhibitors are provided.

参考文章(108)
T. W. Rall, Earl W. Sutherland, THE RELATION OF ADENOSINE-3', 5'-PHOSPHATE AND PHOSPHORYLASE TO THE ACTIONS OF CATECHOLAMINES AND OTHER HORMONES Pharmacological Reviews. ,vol. 12, pp. 265- 299 ,(1960)
Kjell Ingvar Leopold Wetterlin, Leif Ake Svensson, Orally active bronchospasmolytic compounds ,(1975)
Paul Andrews, Anthony Woods, John Watson, Prokinetic agents for treating gastric hypomotility and related disorders ,(1999)
Norihito Ohi, Takafumi Motoki, Yoshimitsu Naoe, Taro Terauchi, Motohiro Soejima, Nobuaki Sato, Takashi Doko, Pyrazole compounds and pharmaceutical compositions comprising the compound ,(2003)
Bradley D. Anderson, Robert A. Conradi, Sulfonate containing ester prodrugs of corticosteroids ,(1983)
Luciano Toscano, Mario Riva, Steroids and process for preparing the same ,(1979)